Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Prazepam

Known as: 2H-1,4-Benzodiazepin-2-one, 7-chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-, Prazepam [Chemical/Ingredient], Prazepamum 
A benzodiazepine that is used in the treatment of ANXIETY DISORDERS.
National Institutes of Health

Related topics

Related topics

24 relations
Alcohol Withdrawal DeliriumAngle Closure GlaucomaAnxiety DisordersDrug Allergy
Expand

Broader (4)

Anti-Anxiety AgentsBenzodiazepinonesGABA ModulatorsMuscle Relaxants, Central

Narrower (2)

CentraxLysanxia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Spatio-temporal evaluation of organic contaminants and their transformation products along a river basin affected by urban, agricultural and industrial pollution.
This study aims to assess the occurrence, fate and temporal and spatial distribution of anthropogenic contaminants in a river… Expand
  • table 1
  • figure 1
  • table 2
  • table 2
  • figure 2
Highly Cited
2004
Highly Cited
2004
Screening, library-assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography/mass spectrometry with…
A liquid chromatographic/mass spectrometric assay with atmospheric pressure chemical ionization (LC/APCI-MS) is presented for… Expand
Review
2003
Review
2003
Serotonin syndrome: a brief review.
Case 1 A 50-year-old man was admitted to hospital with hyperhidrosis, nausea, vomiting and diarrhea. He had been taking… Expand
  • figure 1
  • table 1
  • table 2
Review
2003
Review
2003
Anti-spasticity agents for multiple sclerosis.
BACKGROUND Spasticity is a common problem in MS patients causing pain, spasms, loss of function and difficulties in nursing care… Expand
Review
2000
Review
2000
Anti-spasticity agents for multiple sclerosis.
BACKGROUND Spasticity is a common problem in MS patients causing pain, spasms, loss of function and difficulties in nursing care… Expand
Highly Cited
1999
Highly Cited
1999
Biologically Active Natural Products : Agrochemicals
Agrochemicals and Pharmaceuticals: The Connection-Horace G. Cutler, and Stephen J. Cutler Terpenoids With Potential Use as… Expand
  • figure 1.1
  • figure 1.2
  • figure 1.3
  • figure 1.4
  • figure 1.6
Review
1989
Review
1989
Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.
Ranitidine, a histamine H2-receptor antagonist, is now well established as a potent inhibitor of gastric acid secretion effective… Expand
  • figure 1
  • figure 2
  • figure 3
  • table I
  • table II
Highly Cited
1988
Highly Cited
1988
Comparative single‐dose kinetics and dynamics of lorazepam, alprazolam, prazepam, and placebo
Thirty‐nine healthy volunteers received single oral doses of either alprazolam (1 mg), lorazepam (2 mg), prazepam (20 mg), or… Expand
Highly Cited
1980
Highly Cited
1980
Desmethyldiazepam kinetics in the elderly after oral prazepam
Our subjects were 15 young (aged 22 to 42 yr) and 14 elderly (aged 62 to 85 yr) people who took single oral doses of 20 mg… Expand
Review
1978
Review
1978
Prazepam and lorazepam, two new benzodiazepines.
THE neuropharmacologic properties of the many benzodiazepine derivatives available for clinical use are qualitatively similar if… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE